These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8941624)

  • 1. Treatment of post-transplant erythrocytosis by angiotensin II type I receptor antagonists.
    Eustace JA; Mellotte GJ; Keogn JA
    Nephrol Dial Transplant; 1996 Nov; 11(11):2373-4. PubMed ID: 8941624
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of post kidney transplantation erythrocytosis (PTE) with ACE inhibitors].
    Morale W; Puliatti C; Veroux P; Veroux M; Valvo C; Cappello D; Puliatti D; Francesco L
    Minerva Urol Nefrol; 2002 Sep; 54(3):189-92. PubMed ID: 12384621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Losartan in post-transplant erythrocytosis.
    Conlon PJ; Smith SR; Butterly DW; Brennan DC
    Nephrol Dial Transplant; 1996 Dec; 11(12):2524-5. PubMed ID: 9017645
    [No Abstract]   [Full Text] [Related]  

  • 4. Losartan versus ramipril in the treatment of postrenal transplant erythrocytosis.
    Hortal L; Fernández A; Vega N; Rodríguez JC; Losada A; Lorenzo M; Plaza C; Palop L
    Transplant Proc; 1998 Aug; 30(5):2127-8. PubMed ID: 9723415
    [No Abstract]   [Full Text] [Related]  

  • 5. Benefit of angiotensin II receptor blockade in the treatment of posttransplant polycythemia in renal transplant recipients.
    Kupin W; Venkat KK; Goggins M; Abouljoud M; Escobar F; Mozes M
    Transplant Proc; 1997; 29(1-2):207-8. PubMed ID: 9122965
    [No Abstract]   [Full Text] [Related]  

  • 6. Post-transplant erythrocytosis refractory to ACE inhibitors and angiotensin receptor blockers.
    Vishnu P; Moreno Vanegas Y; Wadei HM; Rivera CE
    BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29954763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of postrenal transplant erythrocytosis. Long-term efficacy and safety of angiotensin-converting enzyme inhibitors.
    MacGregor MS; Rowe PA; Watson MA; Rodger RS; Junor BJ; Briggs JD
    Nephron; 1996; 74(3):517-21. PubMed ID: 8938674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of post kidney transplantation erythrocytosis (PTE) with ACE inhibitors].
    Morale W; Puliatti C; Veroux P; Veroux M; Valvo C; Cappello D; Puliatti D; Francesco L
    Minerva Urol Nefrol; 2002 Jun; 54(2):145-8. PubMed ID: 12070465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights and treatment in posttransplant polycythemia (erythrocytosis) of renal recipients.
    Sauron C; Berthoux P; Berthoux F; Alamartine E; Diab N; Broyet C; Hacini J
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1032-3. PubMed ID: 8382847
    [No Abstract]   [Full Text] [Related]  

  • 10. Routine renin-angiotensin system blockade in renal transplantation?
    Remuzzi G; Perico N
    Curr Opin Nephrol Hypertens; 2002 Jan; 11(1):1-10. PubMed ID: 11753080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term therapy for postrenal transplant erythrocytosis with ACE inhibitors: efficacy, safety and action mechanisms.
    Montanaro D; Groupuzzo M; Boscutti G; Risaliti A; Bresadola F; Mioni G
    Clin Nephrol; 2000 Apr; 53(4):suppl 47-51. PubMed ID: 10809436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of losartan on the treatment of posttransplant erythrocytosis.
    Navarro JF; García J; Macía M; Mora C; Chahin J; Gallego E; Méndez ML; del Castillo N
    Clin Nephrol; 1998 Jun; 49(6):370-2. PubMed ID: 9696433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibitor-induced anemia and treatment for erythrocytosis in renal transplant recipients.
    Satoh S; Kaneko T; Seino K; Abe T; Omori S; Sugimura J; Fujioka T; Kubo T
    Nihon Jinzo Gakkai Shi; 1995 Jun; 37(6):343-7. PubMed ID: 7666600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful long-term treatment of post-transplant erythrocytosis with losartan.
    Midtvedt K; Stokke ES; Hartmann A
    Nephrol Dial Transplant; 1996 Dec; 11(12):2495-7. PubMed ID: 9017632
    [No Abstract]   [Full Text] [Related]  

  • 15. Postrenal transplant erythrocytosis: risk factors and effectiveness of angiotensin receptor antagonists.
    Singh V; Sud K; Mittal BR; Kohli HS; Gupta KL; Sakhuja V
    Transplant Proc; 2002 Dec; 34(8):3191-2. PubMed ID: 12493416
    [No Abstract]   [Full Text] [Related]  

  • 16. Neutropenia after treatment of posttransplantation erythrocytosis with enalapril.
    Donadio C; Lucchesi A
    Transplantation; 2001 Aug; 72(3):553-4. PubMed ID: 11503000
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of the angiotensin-converting enzyme inhibitor enalapril on post-transplant erythrocytosis.
    Marubayashi S; Yamamoto H; Shibata S; Fudaba Y; Miyata Y; Fukuma K; Okada K; Hinoi T; Ikeda M; Maeda T; Oshiro Y; Dohi K
    Hiroshima J Med Sci; 1998 Sep; 47(3):121-4. PubMed ID: 9810784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of posttransplant erythrocytosis with enalapril.
    Javid R; Ghahramani N; Malek-Hosseini SA; Behzadi S; Rais-Jalali GA
    Transplant Proc; 1999 Dec; 31(8):3226. PubMed ID: 10616453
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomized placebo-controlled study of enalapril in the treatment of erythrocytosis after renal transplantation.
    Beckingham IJ; Woodrow G; Hinwood M; Rigg KM; Morgan AG; Burden RP; Broughton-Pipkin F
    Nephrol Dial Transplant; 1995 Dec; 10(12):2316-20. PubMed ID: 8808232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of post-renal transplant erythrocytosis and microalbuminuria: response to angiotensin-converting enzyme inhibition.
    Mulhern JG; Lipkowitz GS; Braden GL; Madden RL; O'Shea MH; Harvilchuck H; Guarnera JM; Germain MJ
    Am J Nephrol; 1995; 15(4):318-22. PubMed ID: 7573190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.